Project Details
Projekt Print View

Novel statistical and bioinformatic methods to identify genetic factors involved in cognitive decline and rate of disease progression in pre-dementia stages of Alzheimer's disease

Subject Area Biological Psychiatry
Human Cognitive and Systems Neuroscience
Molecular Biology and Physiology of Neurons and Glial Cells
Term from 2019 to 2024
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 429106243
 
Final Report Year 2024

Final Report Abstract

Alzheimer's disease (AD) is the primary cause of dementia, which imposes significant societal costs, accounting for about 1% of the global GDP. Delaying the onset of dementia in AD patients by five years could substantially reduce the financial burden of treatment by 2050. Given that AD has a strong genetic basis, many of the disease's pathological pathways are likely influenced by genetic determinants, affecting protein function and expression. To better understand these pathways, we have developed a novel pathway score-based regression approach. This method, which also incorporates longitudinal data and allows for time-dependent effects, has been used to explore genetic data from patients at prodromal stages of AD, i.e., mild cognitive impairment. Preliminary analysis using 22 selected pathways identified four potentially significant pathways, though further validation is needed. We are in the process of preparing a software package that will be made freely available. In addition to genetic analysis, the project also explored epigenetic changes through the largest AD case-control meta-analysis conducted by the EADB consortium. The study found methylation changes at specific CpGs within AD risk loci, which mediate the genetic effects observed in a genome-wide association study (GWAS). The pathway-based analysis approach was also successfully applied in collaborative works, leading to several publications. The pipeline is designed to be adaptable, allowing for the incorporation of new methods for evaluating the functional consequences of genetic variants and for analyzing different phenotypes. This adaptability suggests that the pathway analysis pipeline will be a valuable tool for future genetic research in AD and other phenotypes beyond neurodegeneration.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung